Diabeta
New Diabetes Drug Expected This Week »
"April 11, 2013 -- A new oral diabetes drug is expected to arrive on pharmacy shelves in the U.S. this week.
Many people predict that Invokana (canagliflozin), approved by the FDA in March, will be a brisk seller. That's partly because i"...
DiaBeta
Diaβeta®
(glyburide) Tablets USP 1.25, 2.5 and 5 mg
DRUG DESCRIPTION
Diaβeta® (glyburide) is an oral blood-glucose-lowering drug of the sulfonylurea class. It is a white, crystalline compound, formulated as tablets of 1.25 mg, 2.5 mg, and 5 mg strengths for oral administration. Diaβeta tablets USP contain the active ingredient glyburide and the following inactive ingredients: dibasic calcium phosphate USP, magnesium stearate NF, microcrystalline cellulose NF, sodium alginate NF, talc USP. Diaβeta (glyburide tablets) 1.25 mg tablets USP also contain D&C Yellow #10 Aluminum Lake and FD&C Red #40 Aluminum Lake. Diaβeta (glyburide tablets) 2.5 mg tablets USP also contain FD&C Red #40 Aluminum Lake. Diaβeta (glyburide tablets) 5 mg tablets USP also contain D&C Yellow #10 Aluminum Lake, and FD&C Blue #1. Chemically, Diaβeta (glyburide tablets) is identified as 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea.
The CAS Registry Number is 10238-21-8.
The structural formula is:
 |
The molecular weight is 493.99. The aqueous solubility of Diaβeta (glyburide tablets) increases with pH as a result of salt formation.
Last reviewed on RxList: 8/3/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional DiaBeta Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
